Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis
- First Online:
- 225 Downloads
To determine whether ingestion of milk thistle affects the pharmacokinetics of indinavir.
We conducted a three-period, randomized controlled trial with 16 healthy participants. We randomized participants to milk thistle or control. All participants received initial dosing of indinavir, and baseline indinavir levels were obtained (AUC0-8) (phase I). The active group were then given 450 mg milk-thistle extract capsules to be taken t.i.d. from day 2 to day 30. The control group received no plant extract. On day 29 and day 30, indinavir dosing and sampling was repeated in both groups as before (phase II). After a wash-out period of 7 days, indinavir dosing and sampling were repeated as before (phase III).
All participants completed the trial, but two were excluded from analysis due to protocol violation. There were no significant between-group differences. Active group mean AUC0-8 indinavir decreased by 4.4% (90% CI, −27.5% to −26%, P=0.78) from phase I to phase II in the active group, and by 17.3% (90% CI, −37.3% to +9%, P=0.25) in phase III. Control group mean AUC0-8 decreased by 21.5% (90% CI, −43% to +8%, P=0.2) from phase I to phase II and by 38.5% (90% CI, −55.3% to −15.3%, P=0.01) of baseline at phase III. To place our findings in context, milk thistle–indinavir trials were identified through systematic searches of the literature. A meta-analysis of three milk thistle–indinavir trials revealed a non-significant pooled mean difference of 1% in AUC0-8 (95% CI, −53% to 55%, P=0.97).
Indinavir levels were not reduced significantly in the presence of milk thistle.
KeywordsMilk thistle Indinavir Randomized controlled trial Pharmacokinetics Drug interactions
- 3.The 8 most important supplements for people on HAART (1999) STEP perspect 99:18Google Scholar
- 4.Venkataramanan R, Ramachandran V, Komoroski BJ, Zhang S, Schiff PL, Strom SC (2000) Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metab Dispos 28:1270–1273Google Scholar
- 5.Foster BC, Drouin CE, Livesey J, Arenson JT, Mills E (2004) In vitro activity of milk thistle against cytochrome P450 isozymes. Int JNM 1:49–52Google Scholar
- 8.Mills EJ, Perri D, Phillips E, Koren G (2004) Natural health products-HIV drug interactions: a systematic review. Int J STD AIDS (in press)Google Scholar
- 10.Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J (2002) The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 34:234–238Google Scholar
- 12.Mills EJ, Montori VM, Wu P, Gallicano KD, Clarke M, Guyatt G (2004) Herb–drug interactions: a systematic review of clinical trials. Archf Intern Med [Abstract: presented at the 10th Annual Symposium on Complementary Health Care. London, UK, November 2003]Google Scholar
- 13.Sackett DL (2001) Why randomized controlled trials fail but needn‘t: 2. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!). CMAJ 165:1226–1237Google Scholar
- 14.van Heeswijk RP, Veldkamp A, Mulder JW et al (2001) Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience. Antivir Ther 6:201–229Google Scholar
- 15.Choo EF, Leake B, Wandel C et al (2000) Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos 28:655–660Google Scholar
- 18.Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016–1023Google Scholar
- 19.Khaliq Y (1998) Effects og nelfinavir on short and long term plasma exposure of saquinavir in hard gel capsule during bid and tid dosing intervals. In: 4th international congress on drug therapy and HIV Infection. Abstract 327Google Scholar
- 22.Liu JP, Manheimer E, Yang M (2004) Herbal medicines for treating HIV infection and AIDS: a Cochrane systematic review. In: Paper presented at: XV international AIDS Conference, Bangkok, ThailandGoogle Scholar